Promising treatments for blood cancers presented by JTCancerCenter researchers ... EurekAlert (press release) In the current study, 551 patients were randomized to receive either an unrelated donor peripheral blood stem cell transplant or bone marrow transplant. At two years post-treatment, there were no significant differences in patient survival between the ... |
